| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1470-2045(04)01492-5 |
| P698 | PubMed publication ID | 15172356 |
| P2093 | author name string | Dean A Fennell | |
| Robin M Rudd | |||
| P2860 | cites work | Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells | Q42486069 |
| Growth factor responses and protooncogene expression of murine mesothelial cell lines derived from asbestos-induced mesotheliomas | Q42816861 | ||
| Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells | Q43006133 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines | Q43687803 | ||
| Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma | Q43747147 | ||
| Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma | Q43802258 | ||
| The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria | Q43884355 | ||
| Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation | Q43939949 | ||
| AKT and the phosphatidylinositol 3-kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment | Q44319490 | ||
| Simian virus-40 large-T antigen binds p53 in human mesotheliomas. | Q45761189 | ||
| Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo | Q48548442 | ||
| A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay. | Q52101478 | ||
| Apoptosis in development | Q59060825 | ||
| Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium | Q68023181 | ||
| Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture | Q68093801 | ||
| Phase II study of vinorelbine in patients with malignant pleural mesothelioma | Q73250833 | ||
| Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres | Q73336080 | ||
| Alterations of the p16(INK4) locus in human malignant mesothelial tumors | Q74461537 | ||
| Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma | Q77667294 | ||
| Conformation of the Bax C-terminus regulates subcellular location and cell death | Q24534099 | ||
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| The European mesothelioma epidemic | Q24650064 | ||
| Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
| Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma | Q28206578 | ||
| Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) | Q28297419 | ||
| Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death | Q28363890 | ||
| Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species | Q28365278 | ||
| Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase | Q28366319 | ||
| Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis | Q28369114 | ||
| Two CD95 (APO-1/Fas) signaling pathways | Q29619631 | ||
| Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product | Q33183808 | ||
| Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome | Q34154044 | ||
| Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Q34214330 | ||
| Apoptosis: a link between cancer genetics and chemotherapy | Q34520432 | ||
| Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane | Q34647032 | ||
| Targeting Bcl-2 and Bcl-X with nonpeptidic small-molecule antagonists | Q35581826 | ||
| Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody | Q35982617 | ||
| The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas | Q38474132 | ||
| Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2 | Q40623393 | ||
| Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor | Q40732059 | ||
| The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. | Q40741871 | ||
| Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway | Q40752717 | ||
| Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species | Q40769371 | ||
| Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma | Q41047702 | ||
| Manganese superoxide dismutase in human pleural mesothelioma cell lines | Q41246097 | ||
| Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment. | Q42442790 | ||
| P433 | issue | 6 | |
| P921 | main subject | apoptotic process | Q14599311 |
| malignant pleural mesothelioma | Q18557602 | ||
| P304 | page(s) | 354-362 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development | |
| P478 | volume | 5 |
| Q28392105 | A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomas |
| Q42575346 | A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance |
| Q37070229 | Advances in the systemic therapy of malignant pleural mesothelioma |
| Q35959234 | Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma |
| Q28533736 | BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma |
| Q27851697 | BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma. |
| Q52579899 | CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial. |
| Q39313461 | Cell type specificity of signaling: view from membrane receptors distribution and their downstream transduction networks |
| Q36022779 | Chemotherapy options and new advances in malignant pleural mesothelioma |
| Q37259632 | Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis |
| Q37833952 | Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research |
| Q39741953 | Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy |
| Q53214981 | Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma. |
| Q37281015 | Expression of cancer-associated molecules in malignant mesothelioma |
| Q37449036 | Future developments in the management of malignant pleural mesothelioma |
| Q33899105 | Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro |
| Q49996923 | Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications |
| Q58778161 | Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma |
| Q36180331 | In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma |
| Q39864601 | Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. |
| Q62517698 | Malignant pleural mesothelioma: time for translational research |
| Q36741548 | Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids |
| Q38509951 | MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications |
| Q37360580 | New diagnostic and molecular characteristics of malignant mesothelioma |
| Q34360248 | Overview of the biochemical and genetic processes in malignant mesothelioma. |
| Q39831596 | Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure |
| Q28389566 | Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases |
| Q40286029 | Role of thioredoxin-1 in apoptosis induction by alpha-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells |
| Q39123760 | SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma |
| Q33834736 | Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma |
| Q38347433 | The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance |
| Q38855303 | The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition |
| Q45256935 | Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: the role of nuclear factor-kappaB pathway activation |
| Q36755500 | Update on the molecular biology of malignant mesothelioma |
Search more.